Cardioverter Defibrillator Devices Market - Global Opportunity Analysis And Industry Forecast (2017-2022) - Product Image

Cardioverter Defibrillator Devices Market - Global Opportunity Analysis And Industry Forecast (2017-2022)

  • ID: 4455941
  • Report
  • Region: Global
  • 195 Pages
  • Meticulous Market Research Pvt. Ltd.
1 of 5
Cardioverter Defibrillator Devices Market Worth 12,520 Million USD by 2022

FEATURED COMPANIES

  • Fukuda Denshi Co. (Japan)
  • LivaNova PLC (U.K.)
  • Medtronic PLC (Ireland)
  • Progetti Srl (Italy)
  • Schiller AG (Switzerland)
  • MORE

Cardioverter Defibrillator Devices Market Size by Product [Implantable Cardioverter Defibrillator (Transvenous Cardioverter Defibrillator, Subcutaneous Cardioverter Defibrillator), External Cardioverter Defibrillator (Manual External Defibrillator, Automated External Defibrillator, and Wearable External Defibrillator)], and End-User (Hospitals, Ambulatory Surgical Centers, and Others) - Global Opportunity Analysis and Industry Forecast To 2022.

Increasing prevalence of cardiovascular disease, sudden cardiac arrest (SCA), and related death remains a significant public health issue across the globe. Variety of non-pharmacologic therapies for primary and secondary prevention of SCA and their management including implantable and wearable defibrillators are available in the market. Cardioverter defibrillators have become a significant therapeutic modality among all for patients who have had a cardiac arrest or are at risk for life-threatening ventricular arrhythmias.

Numerous technological advances in implantable cardioverter defibrillators have resulted in decreased size, greater ease of placement, increased functionality, and improved efficiency to better manage the critical cardiac conditions, thereby driving its adoption across the globe.

The global cardioverter defibrillator devices market is expected to reach USD 12,520.0 million by 2022, at a CAGR of 4.6% during the forecast period of 2017-2022. Increasing burden of cardiovascular diseases, rising aging population, various technological advancements, and increasing sedentary lifestyle and obesity along with excessive consumption of alcohol & caffeinated products are the key factors driving the growth of this market. In addition to the key drivers, the report further gives an extensive outlook on key industry restraints, and opportunities, listed in the market insights segment.

This comprehensive study on the basis of product types and end users gives an extensive outlook on the key dynamics, trends, advantages, key players, related statistics, and detailed market size & forecasts for each segment and sub-segment covered in the cardioverter defibrillator devices market.

The regional focus of the study has covered five major geographies: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. These regions are further analysed at a country level with the detailed qualitative and quantitative analysis. The geographic analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the demographic & economic impact, government & private investments, and regulatory scenario. The report identifies North America to be the largest market, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. The geographic analysis section also comments on the key market players shaping the growth of the industry in the respective countries.

The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2014-2017). The study has also incorporated the market share analysis of leading players and detailed profiles of top 13 market players across the value chain of the industry, including detailed financial performance, product offerings, and strategic growth initiatives of each player.

The key players operating in the global cardioverter defibrillator devices market are Medtronic PLC (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), LivaNova PLC (U.K.), Stryker Corporation (U.S.), Koninklijke Philips N.V. (The Netherlands), Cardiac Science corporation (U.S.), Zoll medical corporation (U.S.), Nihon Kohden Corporation (Japan), Progetti Srl (Italy), Fukuda Denshi Co. (Japan), and Schiller AG (Switzerland).

Key questions answered in the report:

Increasing prevalence of cardiovascular diseases to drive the adoption of cardioverter defibrillator devices market

  • How does the penetration of implantable cardioverter defibrillator differ from the penetration of external cardioverter defibrillator?
  • Which are the high growth market segments in terms of product type, and regions/countries?

The North American cardioverter defibrillator devices market favors both larger and local manufacturers that compete in multiple segments

  • Who are the top competitors in this market and what strategies do they employ to gain shares?
  • What is driving the growth and which market segments have the most potential for revenue expansion over the forecast period?
  • What strategies should new companies looking to enter this market use to compete effectively?
  • What are the major drivers, restrains, and opportunities in the global cardioverter defibrillator devices market?
  • Who are the major players in various countries and what share of the market do they hold?
  • What are the geographical trends and high growth regions/ countries?

Recent collaborations, partnerships, agreements, and expansions taken place in the cardioverter defibrillator devices space.

  • What companies have recently done partnerships/collaborations/agreements and how will these unions affect the competitive landscape of the implantable cardioverter defibrillator space?
  • Which companies have recently received approvals and how will these approvals promote a competitive advantage?
  • Who are the major players in the global cardioverter defibrillator devices market and what share of the market do they hold?
  • Who are the local emerging players in the global cardioverter defibrillator devices market and how do they compete with the global players?

Scope of the Report:

Market by Product:

Implantable cardioverter defibrillator

  • Transvenous cardioverter defibrillator
  • Single-chamber cardioverter defibrillator
  • Dual-chamber cardioverter defibrillator
  • CRT-Ds/Biventricular cardioverter defibrillator
  • Subcutaneous cardioverter defibrillator

External cardioverter defibrillator

  • Manual external cardioverter defibrillator
  • Automated external cardioverter defibrillator
  • Fully-automated cardioverter defibrillator
  • Semi-automated cardioverter defibrillator
  • Wearable external cardioverter defibrillator

Market by End-user:

  • Hospitals
  • Ambulatory surgery centre
  • Others

Market by Geography:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Rest of Asia-Pacific

Rest of World

  • Latin America
  • Middle East and Africa
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Fukuda Denshi Co. (Japan)
  • LivaNova PLC (U.K.)
  • Medtronic PLC (Ireland)
  • Progetti Srl (Italy)
  • Schiller AG (Switzerland)
  • MORE

1. Introduction
1.1. Market Ecosystem
1.2. Currency And Limitations
1.2.1. Currency
1.2.2. Limitations
1.3. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation

3. Executive Summary

4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Rising Geriatric Population
4.2.2. Increasing Burden of Cardiovascular Diseases
4.2.3. Rise in Obesity, Sedentary Lifestyle, and Excessive Consumption of Alcohol & Caffienated Products
4.2.4. Technological Advancements
4.2.5. Other Drivers
4.3. Restraints
4.3.1. Increase in Reported Cases of Cardioverter Defibrillators Malfunction & Product Recalls
4.3.2. Other Restraints
4.4. Opportunities
4.4.1. Emerging Markets Offer Significant Growth Opportunities
4.4.2. Other Opportunities
4.5. Challenges
4.5.1. Lack of Skilled Professionals
4.5.2. Other Challenges
4.6. Regulatory Analysis
4.6.1. North America
4.6.2. Europe
4.6.3. Asia-Pacific
4.6.4. Rest of World
4.7. Market Share Analysis, by Key Players

5. Cardioverter Defibrillator Devices Market, By Product
5.1. Introduction
5.2. Implantable Cardioverter Defibrillator
5.2.1. Transvenous Implantable Cardioverter Defibrillators
5.2.1.1. Cardiac Resynchronization Therapy Defibrillators (CRT-D)
5.2.1.2. Dual-Chamber Implantable Cardioverter Defibrillators
5.2.1.3. Single-Chamber Implantable Cardioverter Defibrillators
5.2.2. Subcutaneous Implantable Cardioverter Defibrillators
5.3. External Cardioverter Defibrillator
5.3.1. Manual ECD
5.3.2. Automated ECD
5.3.2.1. Semi-Automated ECD
5.3.2.2. Fully-Automated ECD
5.3.3. Wearable ECD

6. Cardioverter Defibrillator Devices Market, By End-User
6.1. Introduction
6.2. Hospitals
6.3. Ambulatory Surgery Centers
6.4. Others

7. Cardioverter Defibrillator Devices Market, By Geography
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.3. Europe
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. RoE
7.4. Asia-Pacific
7.4.1. Japan
7.4.2. China
7.4.3. India
7.4.4. RoAPAC
7.5. Rest of The World (RoW)
7.5.1. Latin America
7.5.2. Middle East & Africa

8. Competitive Landscape
8.1. Approvals
8.2. New Product Launch
8.3. Mergers & Acquisitions
8.4. Expansion
8.5. Partnerships, Agreements, And Collaborations

9. Company Profiles (Business Overview, Recent Financials, Product Portfolio, and Recent Strategic Developments)
9.1. Medtronic PLC
9.2. Boston Scientific Corporation
9.3. Abbott Laboratories
9.4. Biotronik Se & Co., Kg
9.5. Livanova Plc
9.6. Physio-Control, Inc.
9.7. Koninklijke Philips N.V.
9.8. Nihon Kohden Corporation
9.9. Progetti Srl
9.10. Fukuda Denshi Co., Ltd.
9.11. Schiller AG
9.12. Cardiac Science Corporation
9.13. Zoll Medical Corporation

10. Appendix
10.1. Questionnaire
10.2. Available Customization

List of Tables
Table 1 Cardioverter Defibrillator Devices Market Drivers: Impact Analysis (2017-2022)
Table 2 List of Innovative Cardioverter Defibrillators Approved & Launched Recently with Enhanced Features
Table 3 Cardioverter Defibrillator Devices Market Restraints: Impact Analysis (2017-2022)
Table 4 Number of Cardiac Implant Recalls & Total Recall Reports, 2004-2014
Table 5 Global Cardioverter Defibrillators Devices Market Size, by Type, 2015-2022 (USD Million)
Table 6 Global ICDs Market Size, by Type, 2015-2022 (USD Million)
Table 7 Global ICDs Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 8 List of FDA Approved Transvenous ICDs:
Table 9 Global Transvenous ICDs Market Size, by Type, 2015-2022 (USD Million)
Table 10 Global Transvenous ICDs Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 11 Global Biventricular ICDs Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 12 Global Dual Chamber ICDs Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 13 Global Single Chamber ICDs Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 14 FDA Approved Subcutaneous ICDs:
Table 15 Global Subcutaneous ICDs Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 16 Global ECDs Market Size, by Type, 2015-2022 (USD Million)
Table 17 Global ECDs Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 18 Global Manual ECDs Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 19 Global Automated ECDs Market Size, by Type, 2015-2022 (USD Million)
Table 20 Global Automated ECDs Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 21 Global Semi-Automated ECDs Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 22 Global Fully Automated ECDs Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 23 Global Wearable ECDs Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 24 Global Cardioverter Defibrillators Devices Market Size, by End-User, 2015-2022 (USD Million)
Table 25 Reimbursement Prospectus for Hospital Outpatient Procedure in The U.S.
Table 26 The U.S. National Medicare Hospital Outpatient Payment Rates for Medtronic Therapies
Table 27 Global Cardioverter Defibrillators Devices Market Size for Hospitals, 2015-2022 (USD Million)
Table 28 Changes in Ambulatory Surgery Center Reimbursement Fee Schedule in The U.S., 2016-2017
Table 29 Reimbursement Prospectus of Ambulatory Surgical Center in The U.S. By Procedure
Table 30 Global Cardioverter Defibrillators Devices Market Size for Ambulatory Surgery Center, 2015-2022 (USD Million)
Table 31 Global Cardioverter Defibrillators Devices Market Size for Other End Users, 2015-2022 (USD Million)
Table 32 Global Cardioverter Defibrillator Devices Market Size, by Country, 2015-2022 (USD Million)
Table 33 North America: Cardioverter Defibrillator Devices Market Size, by Country, 2015-2022 (USD Million)
Table 34 North America: Market Size, by Product, 2015-2022 (USD Million)
Table 35 North America: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 36 North America: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 37 North America: External Cardioverter Defibrillator Devices Market Size, by Type, 2015-2022 (USD Million)
Table 38 North America: Automated External Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 39 North America: Market Size, by End-User, 2015-2022 (USD Million)
Table 40 U.S.: Market Size, by Product, 2015-2022 (USD Million)
Table 41 U.S.: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 42 U.S.: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 43 U.S.: External Cardioverter Defibrillator Devices Market Size, by Type, 2015-2022 (USD Million)
Table 44 U.S.: Automated External Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 45 U.S.: Market Size, by End-User, 2015-2022 (USD Million)
Table 46 Canada: Size, by Product, 2015-2022 (USD Million)
Table 47 Canada: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 48 Canada: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 49 Canada: External Cardioverter Defibrillator Devices Market Size, by Type, 2015-2022 (USD Million)
Table 50 Canada: Automated External Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 51 Canada: Market Size, by End-User, 2015-2022 (USD Million)
Table 52 Europe: Market Size, by Country, 2015-2022 (USD Million)
Table 53 Europe: Market Size, by Product, 2015-2022 (USD Million)
Table 54 Europe: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 55 Europe: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 56 Europe: External Cardioverter Defibrillator Devices Market Size, by Type, 2015-2022 (USD Million)
Table 57 Europe: Automated External Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 58 Europe: Market Size, by End-User, 2015-2022 (USD Million)
Table 59 Germany: Market Size, by Product, 2015-2022 (USD Million)
Table 60 Germany: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 61 Germany: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 62 Germany: External Cardioverter Defibrillator Devices Market Size, by Type, 2015-2022 (USD Million)
Table 63 Germany: Automated External Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 64 Germany: Market Size, by End-User, 2015-2022 (USD Million)
Table 65 France: Market Size, by Product, 2015-2022 (USD Million)
Table 66 France: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 67 France: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 68 France: External Cardioverter Defibrillator Devices Market Size, by Type, 2015-2022 (USD Million)
Table 69 France: Automated External Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 70 France: Market Size, by End-User, 2015-2022 (USD Million)
Table 71 U.K.: Cardioverter Defibrillator Devices Market Size, by Product, 2015-2022 (USD Million)
Table 72 U.K.: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 73 U.K.: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 74 U.K.: External Cardioverter Defibrillator Devices Market Size, by Type, 2015-2022 (USD Million)
Table 75 U.K.: Automated External Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 76 U.K.: Market Size, by End-User, 2015-2022 (USD Million)
Table 77 Italy: Cardioverter Defibrillator Devices Market Size, by Product, 2015-2022 (USD Million)
Table 78 Italy: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 79 Italy: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 80 Italy: External Cardioverter Defibrillator Devices Market Size, by Type, 2015-2022 (USD Million)
Table 81 Italy: Automated External Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 82 Italy: Market Size, by End-User, 2015-2022 (USD Million)
Table 83 Spain: Cardioverter Defibrillator Devices Market Size, by Product, 2015-2022 (USD Million)
Table 84 Spain: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 85 Spain: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 86 Spain: External Cardioverter Defibrillator Devices Market Size, by Type, 2015-2022 (USD Million)
Table 87 Spain: Automated External Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 88 Spain: Market Size, by End-User, 2015-2022 (USD Million)
Table 89 RoE: Market Size, by Product, 2015-2022 (USD Million)
Table 90 RoE: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 91 RoE: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 92 RoE: External Cardioverter Defibrillator Devices Market Size, by Type, 2015-2022 (USD Million)
Table 93 RoE: Automated External Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 94 RoE: Market Size, by End-User, 2015-2022 (USD Million)
Table 95 APAC: Cardioverter Defibrillator Devices Market Size, by Country, 2015-2022 (USD Million)
Table 96 APAC: Market Size, by Product, 2015-2022 (USD Million)
Table 97 APAC: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 98 APAC: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 99 APAC: External Cardioverter Defibrillator Devices Market Size, by Type, 2015-2022 (USD Million)
Table 100 APAC: Automated External Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 101 APAC: Market Size, by End-User, 2015-2022 (USD Million)
Table 102 Japan: Cardioverter Defibrillator Devices Market Size, by Product, 2015-2022 (USD Million)
Table 103 Japan: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 104 Japan: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 105 Japan: External Cardioverter Defibrillator Devices Market Size, by Type, 2015-2022 (USD Million)
Table 106 Japan: Automated External Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 107 Japan: Market Size, by End-User, 2015-2022 (USD Million)
Table 108 China: Cardioverter Defibrillator Devices Market Size, by Product, 2015-2022 (USD Million)
Table 109 China: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 110 China: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 111 China: External Cardioverter Defibrillator Devices Market Size, by Type, 2015-2022 (USD Million)
Table 112 China: Automated External Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 113 China: Market Size, by End-User, 2015-2022 (USD Million)
Table 114 India: Cardioverter Defibrillator Devices Market Size, by Product, 2015-2022 (USD Million)
Table 115 India: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 116 India: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 117 India: External Cardioverter Defibrillator Devices Market Size, by Type, 2015-2022 (USD Million)
Table 118 India: Automated External Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 119 India: Market Size, by End-User, 2015-2022 (USD Million)
Table 120 RoAPAC: Cardioverter Defibrillator Devices Market Size, by Product, 2015-2022 (USD Million)
Table 121 RoAPAC: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 122 RoAPAC: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 123 RoAPAC: External Cardioverter Defibrillator Devices Market Size, by Type, 2015-2022 (USD Million)
Table 124 RoAPAC: Automated External Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 125 RoAPAC: Cardioverter Defibrillator Devices Market Size, by End-User, 2015-2022 (USD Million)
Table 126 RoW: Cardioverter Defibrillator Devices Market Size, by Country, 2015-2022 (USD Million)
Table 127 RoW: Market Size, by Product, 2015-2022 (USD Million)
Table 128 RoW: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 129 RoW: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 130 RoW: External Cardioverter Defibrillator Devices Market Size, by Type, 2015-2022 (USD Million)
Table 131 RoW: Automated External Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 132 RoW: Market Size, by End-User, 2015-2022 (USD Million)
Table 133 Latin America: Cardioverter Defibrillator Devices Market Size, by Product, 2015-2022 (USD Million)
Table 134 Latin America: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 135 Latin America: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 136 Latin America: External Cardioverter Defibrillator Devices Market Size, by Type, 2015-2022 (USD Million)
Table 137 Latin America: Automated External Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 138 Latin America: Market Size, by End-User, 2015-2022 (USD Million)
Table 139 Middle East & Africa: Cardioverter Defibrillator Devices Market Size, by Type, 2015-2022 (USD Million)
Table 140 Middle East & Africa: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 141 Middle East & Africa: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 142 Middle East & Africa: External Cardioverter Defibrillator Devices Market Size, by Type, 2015-2022 (USD Million)
Table 143 Middle East & Africa: Automated External Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 144 Middle East & Africa: Market Size, by End-User, 2015-2022 (USD Million)
Table 145 Number of Developments Done by The Profiled Companies, 2015-2017
Table 146 Approvals
Table 147 New Product Launches
Table 148 Mergers & Acquisitions
Table 149 Expansions
Table 150 Partnerships, Agreements, and Collaborations

List of Figures
Figure 1 Research Process
Figure 2 Key Executives Interviewed
Figure 3 Primary Research Techniques
Figure 4 Market Size Estimation
Figure 5 Key Opportunities
Figure 6 Implantable Cardioverter Defibrillator is the Largest Segment Among All Cardioverter Defibrillator Devices
Figure 7 Global Cardioverter Defibrillator Market Size, By Type, 2017-2022 (USD Million)
Figure 8 Bi-Ventricular Chamber Cardioverter Defibrillator Dominates the Transvenous Implantable Cardioverter Defibrillators Market
Figure 9 Hospitals Dominates in Cardioverter Defibrillator Market, by End-User
Figure 10 Global Cardioverter Defibrillator Devices Market Overview -2017-2022
Figure 11 Key Growth Strategies Adopted by Leading Players -2015-2017
Figure 12 Market Dynamics
Figure 13 Share of Geriatric Population 60 Years & Above, by Region, 2010-2020
Figure 14 Percentage Distribution of Population Aged 65 and Over by Region, 2015-2050
Figure 15 Global Cardivascular Diseases Deaths by Type, 2015
Figure 16 Facts About Sudden Cardiac Arrest
Figure 17 Risk of Dying From Alcohol Attributed Cause in European Region, 2016
Figure 18 Ratio of Total Number Of Cardiac Implants Recalls, 2015
Figure 19 Percentage Distribution Of Population Aged 65 and Over by Region, 2015-2050
Figure 20 Total Physician Shortage in the U.S., 2015-2030
Figure 21 Regulatory Approval Pathway in the U.S.
Figure 22 Global Cardioverter Defibrillator Devices Market Share, by Key Players, 2016
Figure 23 Facts About Sudden Cardiac Arrest
Figure 24 Percentage Breakdown of Death Due To CVD in the U.S., 2014
Figure 25 Number of Hospitals in Health System in the U.S., 2004-2014
Figure 26 Number of Medicare-Certified Ambulatory Surgical Centres in the U.S., 2009-2014
Figure 27 Global Facts About Hypertension
Figure 28 Global Cardioverter Defibrillator Devices Market Size, by Region, 2015-2022 (USD Million)
Figure 29 Projected Number Of Geriatric Population (Aged 65 Years & Above) in the U.S., 2000-2030
Figure 30 Total Deaths By Disease Category in the U.S.- 2015
Figure 31 A Snapshot of High Blood Pressure in the U.S., 2014
Figure 32 Ageing Population in Canada
Figure 33 Snapshot of Cardiovascular Disease in Europe, 2017
Figure 34 The Share of Death By Cause in European Males, 2016
Figure 35 The Share of Death By Cause in European Females, 2016
Figure 36 Total Number of Deaths From CVD in Major European Countries, 2014-2020
Figure 37 Change in Population Structure in Germany, 2015-2025
Figure 38 Total Number of Death By Cause, 2014
Figure 39 Percentage of Population Aged 65 Years and Above (% Of Total), 2011-2015
Figure 40 Incidence Of CVD, IHD And Stroke in France, by Sex- 2015
Figure 41 Incidence Of Cardiovascular Disease in France, by Sex, 2000-2015
Figure 42 Share Of Aged Population in the Total Population of the U.K., 2005-2045
Figure 43 The Share Of Death by Cause in the U.K. Womens, 2014
Figure 44 The Share Of Death by Cause in the U.K. Men,2014
Figure 45 Incidence Of Cardiovascular Disease in Italy, by Sex, 2000-2015
Figure 46 Incidence Of CVD, IHD and Stroke in Italy, by Sex, 2015
Figure 47 Incidence Of CVD, IHD and Stroke in Spain, by Sex, 2015
Figure 48 Proportion Of Mortality in Japan by Therapeutic Area, 2014
Figure 49 Share Of Aging Population in Total Chinese Population, 2011-2016 (%)
Figure 50 Major Causes Of Death in China, 2014
Figure 51 Mortality Trends in China, 2010-2014
Figure 52 Number Of Cases Of Coronary Heart Disease (Chd) In India, 2000-2015
Figure 53 Principle Causes Of Death In Malaysia, 2013-2014
Figure 54 Number Of Person Aged 60 Years & Above In Latin America, 2015-2030
Figure 55 Key GroWth Strategies Adopted By Key Players -2015-2017
Figure 56 Regulatory Approvals Received By Profiled Companies, 2015-2017
Figure 57 New Product Launch By Profiled Companies, 2015-2017
Figure 58 Mergers & Acquisitions By Profiled Companies, 2015-2017
Figure 59 Medtronic PLC: Financial Overview - 2015-2017
Figure 60 Boston Scientific Corporation: Financial Overview - 2014-2016
Figure 61 Abbott Laboratories: Financial Overview - 2014-2016
Figure 62 Livanova PLC: Financial Overview - 2015 & 2016
Figure 63 Stryker Corporation (A Parent Company of Physio-Control Inc.): Financial Overview - 2014-2016
Figure 64 Koninklijke Philips N.V.: Financial Overview - 2014-2016
Figure 65 Nihon Kohden Corporation: Financial Overview - 2015-2017
Figure 66 Fukuda Denshi Co., Ltd.: Financial Overview - 2015-2017

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Abbott Laboratories (U.S.)
  • BIOTRONIK SE & Co. KG (Germany)
  • Boston Scientific Corporation (U.S.)
  • Cardiac Science corporation (U.S.)
  • Fukuda Denshi Co. (Japan)
  • Koninklijke Philips N.V. (Netherlands)
  • LivaNova PLC (U.K.)
  • Medtronic PLC (Ireland)
  • Nihon Kohden Corporation (Japan)
  • Progetti Srl (Italy)
  • Schiller AG (Switzerland)
  • Stryker Corporation (U.S.)
  • Zoll medical corporation (U.S.)
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll